Based on recent data, Kyverna Therapeutics, Inc. (KYTX) shows an Average True Range (ATR) of 0.58 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 872.94K, indicating liquidity. These fundamental metrics provide insight into KYTX's underlying financial health and market activity.
| ATR | 0.58 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 872.94K |
| Avg Vol (10 Days) | 1.05M |
Kyverna Therapeutics, Inc. (KYTX) technical indicators as of May 15, 2026: the SMA 20 is 3.49%, SMA 50 at -3.67%, and SMA 200 at 42.13%. The RSI 14 value is 50.8, suggesting its current momentum. These technical analysis signals help assess KYTX's price trends and potential future movements.
| SMA 20 | 3.49% |
| SMA 50 | -3.67% |
| SMA 200 | 42.13% |
| RSI 14 | 50.8 |
Kyverna Therapeutics, Inc. (KYTX) stock performance overview as of May 15, 2026: The 52-week high is $13.67 (currently -40.6% below), and the 52-week low is $2.06 (currently 356.18% above). Over the past year, KYTX's performance is 162.97%, compared to the S&P 500's 11.62% change.
| 52-Week High | 13.67 |
| 52-Week High Chg | -40.60% |
| 52-Week Low | 2.06 |
| 52-Week Low Chg | +356.18% |
| S&P 500 52-Week Chg | 11.62% |
According to market data, Kyverna Therapeutics, Inc. (KYTX) stock's recent performance metrics show that over the last month, KYTX is 30.54%, with a Year-to-Date (YTD) performance of -4.04%. Over the past year, the stock has seen a 162.97% change. These figures summarize KYTX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 11.15 | 11.62 | 11.62 | 13.67 | 13.67 | 11.62 |
| Low | 9.31 | 8.25 | 7.23 | 6.2 | 2.06 | 7.21 |
| Performance | +9.60% | +30.54% | +36.05% | +133.07% | +162.97% | -4.04% |
According to current financial data, KYTX stock's P/E (TTM) ratio is -3.66, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for KYTX, including P/S (N/A), P/B (2.93), and P/FCF (-2.75), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | KYTX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -3.66 | -1.22 | -5.12 | 32.59 |
| P/S (TTM) | N/A | 3.69 | 464.32 | 5.98 |
| P/B (TTM) | 2.93 | -0.24 | 17.46 | 4.58 |
| P/FCF (TTM) | -2.75 | 59.59 | -413.93 | 31.83 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep